Table 2 Confirmed antitumor activity after conversion therapy
RECIST 1.1 | mRECIST | |||||
|---|---|---|---|---|---|---|
Variable | LENTAP | TACE | P value | LENTAP | TACE | P value |
Objective response | 27 (38.0) | 5 (7.0) | <0.001 | 56 (78.9) | 12 (16.9) | <0.001 |
Complete response | 1 (1.4) | 0 (0) | 13 (18.3) | 0 (0) | ||
Partial response | 26 (36.6) | 5 (7.0) | 43 (60.6) | 12 (16.9) | ||
Stable disease | 39 (54.9) | 27 (38.0) | 11 (15.5) | 21 (29.6) | ||
Disease control | 66 (92.9) | 32 (45.1) | <0.001 | 67 (94.4) | 33 (45.5) | <0.001 |
Progressive disease | 5 (7.0) | 39 (54.9) | 4 (5.6) | 38 (53.5) | ||
Amenable for salvage resection | 58 | 21 | <0.001 | 62 | 25 | <0.001 |
